Procter & Gamble Hygiene and Health Care · NSE: PGHH · BSE: 500459
Q3 FY21 results · Oct–Dec 2020
Procter & Gamble Hygiene and Health Care reported revenue from operations of ₹1,018.44 crore (up 18.5% from Q3 FY20) and net profit of ₹250.62 crore (up 84.4% from Q3 FY20) for Q3 FY21 (Oct–Dec 2020), on a standalone basis.
| Item | Q3 FY21 | Q3 FY20 | YoY | Q2 FY21 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 1,018.44 | 859.27 | +18.5% | 1,009.45 | +0.9% |
| Other income | 9.35 | 9.02 | +3.7% | 9.56 | −2.2% |
| Total income | 1,027.79 | 868.29 | +18.4% | 1,019.01 | +0.9% |
| Profit before tax | 337.71 | 182.00 | +85.6% | 335.70 | +0.6% |
| Net profit for the period | 250.62 | 135.93 | +84.4% | 253.86 | −1.3% |
| EPS, basic (₹) | 77.21 | 41.88 | +84.4% | 78.21 | −1.3% |
| Net margin (%) | 24.6 | 15.8 | 25.1 |
Standalone
- Filed with BSE
- 04 Feb 2021, 16:27 IST
- Board meeting
- 03 Feb 2021
- Period
- 01 Oct 2020 to 31 Dec 2020
- Review status
- Unaudited
- Source
- XBRL filing on BSE